IDXG
Price
$0.79
Change
-$0.01 (-1.25%)
Updated
Sep 5 closing price
Capitalization
3.6M
57 days until earnings call
SDMHF
Price
$204.37
Change
+$0.38 (+0.19%)
Updated
Sep 5 closing price
Capitalization
19.8B
Interact to see
Advertisement

IDXG vs SDMHF

Header iconIDXG vs SDMHF Comparison
Open Charts IDXG vs SDMHFBanner chart's image
Interpace Biosciences
Price$0.79
Change-$0.01 (-1.25%)
Volume$10.45K
Capitalization3.6M
Sartorius Stedim Biotech
Price$204.37
Change+$0.38 (+0.19%)
Volume$58
Capitalization19.8B
IDXG vs SDMHF Comparison Chart in %
Loading...
IDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDMHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXG vs. SDMHF commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXG is a Hold and SDMHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (IDXG: $0.79 vs. SDMHF: $204.37)
Brand notoriety: IDXG and SDMHF are both not notable
IDXG represents the Medical Specialties, while SDMHF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: IDXG: 118% vs. SDMHF: 5%
Market capitalization -- IDXG: $3.49M vs. SDMHF: $19.7B
IDXG [@Medical Specialties] is valued at $3.49M. SDMHF’s [@Pharmaceuticals: Other] market capitalization is $19.7B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.69B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXG’s FA Score shows that 2 FA rating(s) are green whileSDMHF’s FA Score has 0 green FA rating(s).

  • IDXG’s FA Score: 2 green, 3 red.
  • SDMHF’s FA Score: 0 green, 5 red.
According to our system of comparison, IDXG is a better buy in the long-term than SDMHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXG’s TA Score shows that 2 TA indicator(s) are bullish while SDMHF’s TA Score has 5 bullish TA indicator(s).

  • IDXG’s TA Score: 2 bullish, 6 bearish.
  • SDMHF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SDMHF is a better buy in the short-term than IDXG.

Price Growth

IDXG (@Medical Specialties) experienced а -5.11% price change this week, while SDMHF (@Pharmaceuticals: Other) price change was +0.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.73%. For the same industry, the average monthly price growth was +9.08%, and the average quarterly price growth was +18.71%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.99%. For the same industry, the average monthly price growth was +4.58%, and the average quarterly price growth was +17.70%.

Reported Earning Dates

IDXG is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (+1.73% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.99% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDMHF($19.8B) has a higher market cap than IDXG($3.6M). SDMHF has higher P/E ratio than IDXG: SDMHF (75.82) vs IDXG (3.04). SDMHF YTD gains are higher at: 4.805 vs. IDXG (-70.714). SDMHF has higher annual earnings (EBITDA): 740M vs. IDXG (6.03M). SDMHF has more cash in the bank: 745M vs. IDXG (502K). IDXG has less debt than SDMHF: IDXG (3.15M) vs SDMHF (2.97B). SDMHF has higher revenues than IDXG: SDMHF (2.9B) vs IDXG (45.5M).
IDXGSDMHFIDXG / SDMHF
Capitalization3.6M19.8B0%
EBITDA6.03M740M1%
Gain YTD-70.7144.805-1,472%
P/E Ratio3.0475.824%
Revenue45.5M2.9B2%
Total Cash502K745M0%
Total Debt3.15M2.97B0%
FUNDAMENTALS RATINGS
IDXG vs SDMHF: Fundamental Ratings
IDXG
SDMHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10084
PRICE GROWTH RATING
1..100
6555
P/E GROWTH RATING
1..100
1678
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDXG's Valuation (23) in the Servicestothe Health Industry industry is somewhat better than the same rating for SDMHF (76) in the null industry. This means that IDXG’s stock grew somewhat faster than SDMHF’s over the last 12 months.

IDXG's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as SDMHF (100) in the null industry. This means that IDXG’s stock grew similarly to SDMHF’s over the last 12 months.

SDMHF's SMR Rating (84) in the null industry is in the same range as IDXG (100) in the Servicestothe Health Industry industry. This means that SDMHF’s stock grew similarly to IDXG’s over the last 12 months.

SDMHF's Price Growth Rating (55) in the null industry is in the same range as IDXG (65) in the Servicestothe Health Industry industry. This means that SDMHF’s stock grew similarly to IDXG’s over the last 12 months.

IDXG's P/E Growth Rating (16) in the Servicestothe Health Industry industry is somewhat better than the same rating for SDMHF (78) in the null industry. This means that IDXG’s stock grew somewhat faster than SDMHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXGSDMHF
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
56%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
53%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 27 days ago
67%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
IDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SDMHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GFF81.341.66
+2.08%
Griffon Corp
CTLP10.81-0.04
-0.37%
Cantaloupe
ARTW3.21-0.09
-2.73%
Art's-Way Manufacturing Co
RJF165.50-5.59
-3.27%
Raymond James Financial
ACTU8.24-0.48
-5.50%
Actuate Therapeutics Inc

IDXG and

Correlation & Price change

A.I.dvisor tells us that IDXG and TIVC have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDXG and TIVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXG
1D Price
Change %
IDXG100%
-1.45%
TIVC - IDXG
21%
Poorly correlated
+1.03%
SDMHF - IDXG
21%
Poorly correlated
+0.18%
PEN - IDXG
20%
Poorly correlated
+0.62%
ZBH - IDXG
1%
Poorly correlated
+0.93%
SRTS - IDXG
1%
Poorly correlated
+1.57%
More

SDMHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDMHF has been loosely correlated with SOAGY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SDMHF jumps, then SOAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDMHF
1D Price
Change %
SDMHF100%
+0.18%
SOAGY - SDMHF
45%
Loosely correlated
+3.02%
SARTF - SDMHF
41%
Loosely correlated
N/A
RPID - SDMHF
30%
Poorly correlated
+11.48%
JNDOF - SDMHF
29%
Poorly correlated
N/A
SRTOY - SDMHF
22%
Poorly correlated
N/A
More